Rinucumab

Modify Date: 2024-04-09 17:45:44

Rinucumab structure	Common Name	Rinucumab
	CAS Number	1569263-06-4	Molecular Weight	N/A
	Density	N/A	Boiling Point	N/A
	Molecular Formula	N/A	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Rinucumab

Rinucumab (REGN 2176), a monoclonal antibody, is a PDGF inhibitor. Rinucumab (REGN 2176) could be used for the study of neovascular age-related macular degeneration[1].

Properties
Spectrum

Name	Rinucumab

Description	Rinucumab (REGN 2176), a monoclonal antibody, is a PDGF inhibitor. Rinucumab (REGN 2176) could be used for the study of neovascular age-related macular degeneration[1].
Related Catalog	Signaling Pathways >> Protein Tyrosine Kinase/RTK >> PDGFR Research Areas >> Metabolic Disease
References	[1]. Megan Cully, et al. Deal watch: Novartis eyes vision-enhancing therapy for macular degeneration. Nat Rev Drug Discov. 2014 Jul;13(7):487.

No Any Chemical & Physical Properties

Rinucumab

Use of Rinucumab

Names

Rinucumab Biological Activity

Chemical & Physical Properties